Beta-catenin mediates soft tissue contracture in clubfoot.
The contracted tissues from clubfeet resemble tissues from other fibroproliferative disorders such as palmar fibromatosis. Beta-catenin-mediated signaling is a crucial pathway controlling the fibroproliferative response in many fibroproliferative disorders. To determine if beta-catenin signaling plays a role in clubfoot, contracted and less contracted tissues from clubfeet were studied using Western analysis to determine the protein level of beta-catenin. Primary cell cultures were established from these tissues, and they were treated with either lithium to increase beta-catenin or Dickkopf-1 to inhibit beta-catenin. RNA was extracted from the cells and analyzed to determine how beta-catenin regulates expression of Type III collagen, an extracellular matrix protein upregulated in contracted clubfoot tissue. There was a more than twofold increase in beta-catenin protein in the contracted tissues. Treatment with either lithium or Dickkopf-1 showed Type III collagen RNA expression positively correlated with the protein level of beta-catenin. These data support the concept that beta-catenin-mediated signaling plays an important role regulating contracture in clubfeet. Because pharmacologic agents are under development to block this signaling pathway, such drugs could be used in cases of severe stiffness to improve range of motion or to decrease the need for radical surgical approaches.
Poon
Raymond
R
Division of Orthopaedic Surgery, Program in Developmental and Stem Cell Biology, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G1X8, Canada.
Li
Catherine
C
Alman
Benjamin A
BA
D049109:Cell Proliferation; D002478:Cells, Cultured; D003025:Clubfoot / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D024061:Collagen Type III / Q000378:metabolism; D003239:Connective Tissue Cells / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D003286:Contracture; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D018021:Lithium Chloride / Q000494:pharmacology; D010766:Phosphorylation; D012313:RNA / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D015854:Up-Regulation; D051176:beta Catenin / Q000378:metabolism*
C495270:CTNNB1 protein, human; D024061:Collagen Type III; D051176:beta Catenin; D012313:RNA; D000071679:Glycogen Synthase Kinase 3 beta; D038362:Glycogen Synthase Kinase 3; D018021:Lithium Chloride